Financials
- Market Capitalization 23.68 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.vynetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00H5W8GM8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.94
売上高対価格比率
43.53
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4590 | CELU Celularity Inc. - Class A Common Stock | 0.76 USD | 0.00% | +4.11% | -5.00% | -68.60% | 22.00 M USD | ||
| 4592 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.42 USD | +0.94% | +6.82% | +21.13% | -34.42% | 22.24 M USD | ||
| 4596 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 5.17 USD | +3.40% | -12.52% | -50.38% | +310.32% | 21.65 M USD | ||
| 4599 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.70 USD | +2.66% | +1.12% | +17.39% | -14.01% | 21.58 M USD |